Bortezomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Palo Alto Medical Foundation-Camino Division
Mountain View, California, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
- Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
- Holy Cross Hospital
Fort Lauderdale, Florida, United States
- Jupiter Medical Center
Jupiter, Florida, United States
- Mount Sinai Medical Center
Miami Beach, Florida, United States
- Adventhealth Orlando
Orlando, Florida, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Kansas City Nci Community Oncology Research Program
Prairie Village, Kansas, United States
- Walter Reed National Military Medical Center
Bethesda, Maryland, United States
- Minneapolis Va Medical Center
Minneapolis, Minnesota, United States
- Center for Cancer Care and Research
St Louis, Missouri, United States
- Missouri Baptist Medical Center
St Louis, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Frisbie Hospital
Rochester, New Hampshire, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Unc Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- Novant Health Presbyterian Medical Center
Charlotte, North Carolina, United States
- Lenoir Memorial Hospital
Kinston, North Carolina, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- Greenville Health System Cancer Institute-Eastside
Greenville, South Carolina, United States
- Central Vermont Medical Center/national Life Cancer Treatment
Berlin Corners, Vermont, United States
- University of Vermont and State Agricultural College
Burlington, Vermont, United States
- Danville Regional Medical Center
Danville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Jun 2004
- Primary completion
- 31 Oct 2006
- Completion
- 8 Jan 2008
- Last update posted
- 23 Sept 2019
- Registered enrollment
- 55
- Registry id
- NCT00088855
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.